Skip to main content
. Author manuscript; available in PMC: 2020 Jun 15.
Published in final edited form as: Clin Cancer Res. 2019 Aug 27;25(24):7554–7564. doi: 10.1158/1078-0432.CCR-19-1045

Figure 4.

Figure 4.

Determining ADCC with IL-15/IL-15Rα in an orthotopic PDX mouse model. A, Nude mice aged 5 to 6 weeks were injected orthotopically with the PDX SJNBL046_X in the para-adrenal space. Four to 5 weeks after injection, mice with tumor volumes measuring ≥ 10 mm3 by ultrasound were randomly assigned to four therapy groups. B, Therapy schema. Animals received two courses of therapy, each lasting 3 weeks. C, Median tumor growth over time in all four therapy groups. D, Waterfall plots showing the relative tumor volume change at the end of therapy compared to baseline measurements for individual mice in each therapy group.